Low rates of follow-up colonoscopy after an abnormal stool-based screening test may be improved by a simple quality performance measure, researchers said.
While prescription opioids are commonly used to treat moderate to severe pain in cancer patients during treatment, there is less clear guidance on using opioids after treatment ends.